Form 4/A for CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE

Accepted 2025-09-16 00:00:00 ET · period of report 2025-06-30 · accession 0001839066-25-000008 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
A	2025-09-16	2025-06-30	CLOV	Reynoso Jamie L.	CEO, Medicare Advantage	F - Tax	$2.79	-85.6K	2.89M	-3%	-$238.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2025-06-30	F	D	85,596	$2.79	2,887,905	D	—	—	(F1) This Form 4/A is being filed to solely to correct that the total number of restricted stock units (RSUs) received upon determination of the level of performance-based RSU grant was previously reported by the Reporting Person on a Form 4/A, filed on January 3, 2024, as described in Footnote 2 below. (F2) Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 1/3 of the number of earned restricted stock units, as described herein. Represents restricted stock units, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned restricted stock units vested on September 7, 2023, one-third of the number of earned restricted stock units vested on June 30, 2024, and the remaining one-third of the earned restricted stock units vested on June 30, 2025. (F3) Number reflects total directly held Class A Common Stock taking into account the amended number and transactions through June 30, 2025.